🇺🇸 FDA
Patent

US 8865686

Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

granted A61KA61K31/65A61P

Quick answer

US patent 8865686 (Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/65, A61P, A61P35/00